Mankind Pharma Ltd Share Price Today - Mankind Pharma Ltd Stock Price Live NSE/BSE

Mankind Pharma Ltd

NSE: MANKIND BSE: 543904

₹2240.10

(0.11%)

Fri, 20 Mar 2026, 09:09 pm

MTF 5xInvest in Mankind Pharma Ltd with 5x Leverage Buy with MTF

Market Cap923.78B

PE Ratio52.03

Dividend0.04

Health Technology

Pharmaceuticals: Major

24.5K

Mankind Pharma Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
82617.27
Net Profit
2011.12
P/B
6.98
Sector P/E
32.08
P/E
50.22
EV/EBITDA
30.20
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
14.83
ROCE
16.04
Debt/Equity
0.37
EPS (TTM)
45.01
Dividend Yield
0
Book Value
370.27
Interest Cover
6.08

Analysis

No Result Found

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	72.66	72.67	72.68	72.70	72.71
FII	11.34	12.84	13.07	12.92	13.34
DII	13.25	11.92	11.50	11.48	11.06
Public	2.75	2.57	2.75	2.90	2.90
Government	0	0	0.00	0.00	0

Technical Analysis

RSI

37.22

MACD

-20.34

50 DMA

2129.54

200 DMA

2335.71

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	2726.80	2454.20	2350.90	2181.60	2078.30	1909.00	1636.40
Fibonacci	2454.20	2350.07	2285.73	2181.60	2077.47	2013.13	1909.00
Camarilla	2322.57	2297.58	2272.59	2181.60	2222.61	2197.62	2172.63

Pivots Level: Classic

+545.20

2726.80

+272.60

2454.20

+169.30

2350.90

2181.60

Pivot Point

LTP: 2000

-103.30

2078.30

-272.60

1909.00

-545.20

1636.40

Moving Average

SMAEMA

Period

Value

10-EMA
2096.30
20-EMA
2121.01
30-EMA
2127.97
50-EMA
2143.11
100-EMA
2198.94
200-EMA
2279.44

Announcement Date	Purpose	Action	Ex Date
03 Feb 2026	board-meetings	Quarterly Results
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
31 Jul 2025	dividend	₹1.00 Dividend /Share	08 Aug 2025
08 Jul 2025	dividend	Interim Dividend - Rs. - 1	08 Aug 2025
03 Jul 2025	agm
18 Jul 2024	agm
24 Aug 2023	agm

Mankind Pharma Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Lupin Ltd

Divis Laboratories Ltd

Mankind Pharma Ltd About

Mankind Pharma is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. Pursuant to scheme of amalgamation, the Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1991

Headquarters

CEO

RAMESH CHAND JUNEJA

Employees

Contact

Website

http://www.mankindpharma.com

investors@mankindpharma.com

Phone

91-11-47476600

Location

208 Okhla Industrial Estate, Phase-III, New Delhi, New Delhi, 110020

Year	History
2020	Incorporated Lifestar Pharmaceuticals Private Limited in Nepal Launched a dedicated specialty therapeutic division for cardiovascular diseases drugs segment with launch of Cilaheart tablets and Statpure tablets Launched a dedicated specialty therapeutic division for diabetes pharmaceuticals segment with launch of Zukanorm tablets
2021	Incorporated Mankind Pharma FZ-LLC in Dubai, UAE Launched a specialty division for therapeutic respiratory pharmaceuticals with launch of Mlife tablets Entered the specialty therapeutic neuro/central nervous system pharmaceuticals segment with launch of Trugaba-NT tablets and Prebris-MNT tablets
2022	Acquired the pharmaceutical formulations brands in India and Nepal from Panacea Biotec Pharma Limited and Panacea Biotec Limited Entered into transplant segment with the launch of Pangraf Capsules and Mycept tablets amongst others Entered into oncology segment with the launch of Pacliall injection amongst others Acquired the brands Daffy and Combihale from Dr. Reddy’s Laboratories Mankind Life Sciences Private Limited acquired 90.00% of the issued, subscribed and paid-up share capital of Upakarma Ayurveda Private Limited.
2023	Mankind Pharma Sets New Industry Standard with Unprecedented Display on Burj Khalifa, Reinforcing Commitment to Excellence. Mankind Pharma announced its partnership with SpiceJet to raise awareness about DMF-grade API. Mankind Pharma Product Prega News and Sonam Kapoor partners to transform from pregnancy detection card to pregnancy care solution.
2024	Mankind Pharma Completes Landmark Acquisition of BSV. Mankind Pharma and Innovent Biologics Partner to Revolutionize Cancer Care in India with Innovative Immunotherapy Sintilimab. Mankind Pharma Launches 45-Day Healthcare Mission at Mahakumbh Serving Thousands of Pilgrims with Free Health Check-ups. Mankind Pharma Product Healthok has joined hands with Bikanervala.

Client Name	Order Side	QTY	Avg Price	Date
BEIGE LIMITED	Sell	5817874	2124.71	26 Mar 2024
BEIGE LIMITED	Sell	5817873	2120.31	26 Mar 2024
HEMA CIPEF (I) LIMITED	Sell	5626167	1832.8	12 Dec 2023
BEIGE LIMITED	Sell	14410132	1832.43	12 Dec 2023
CAIRNHILL CIPEF LIMITED	Sell	6962233	1832.3	12 Dec 2023
BEIGE LIMITED	Sell	3500000	1832.3	12 Dec 2023
KOTAK FUNDSINDIA MIDCAP FUND	Buy	2029246	1832.3	12 Dec 2023

Mankind Pharma Ltd News

Mankind Pharma Acquires Rivotril Brand Rights

Mankind Pharma has acquired exclusive rights to manufacture, market and distribute Rivotril brand from Roche for the Indian market, strengthening its CNS therapy portfolio with this clonazepam reference brand.

18 Mar 2026

companies

Mankind Pharma Acquires Rivotril Brand Rights

Mankind Pharma has purchased the Rivotril brand in India, securing exclusive rights for production, sales, and distribution to strengthen its central nervous system treatment portfolio.

18 Mar 2026

companies

Mankind Pharma Allots 23,256 Shares Under ESOP Plan

Mankind Pharma's board approved allotment of 23,256 equity shares to eligible employees under ESOP Plan 2022, increasing paid-up capital to ₹41,28,28,328 with exercise price of ₹860 per share.

16 Mar 2026

companies

Mankind Pharma clarifies volume surge to BSE

Mankind Pharma responds to BSE inquiry about increased trading volume, attributing it to market conditions while confirming compliance with disclosure norms.

27 Feb 2026

stocks

Mankind Pharma Wins CGST Appeal, Penalty Dropped

Mankind Pharma successfully appeals CGST penalty order, with Commissioner dropping INR 1,02,05,688 penalty imposed under Section 74 of CGST Act for FY 2017-18 to 2020-21.

26 Feb 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800